Mlp Saglik Hizmetleri As Class B · BIST:MPARK
Mlp Saglik Hizmetleri As Class B — MLP Care — Q1 2025 Earnings Presentation
18 slides from Mlp Saglik Hizmetleri As Class B's earnings presentation, May 8, 2025
Slide 1: MLPCARE Q1 2025 Presentation
MLPCARE Q1 2025 PRESENTATION M a y 8 th, 2 0 2 5
Slide 2: Forward Looking Statements
Forward Looking Statements This presentation may contain certain forward-looking statements concerning MLP Care’s future performance and should be considered as good faith estimates made by the Company. These forward-looking statements reflect management expectations and are based upon currently ava
Slide 3: Muharrem Usta, Chairman & CEO
MUHARREM USTA CHAIRMAN & CEO
Slide 4: Q1 2025 Financials at a Glance
Q1 2025 Financials at a Glance • Strong growth in both top and bottom line Revenue EBITDA • Revenue growth supported by domestic TL 11,754 m TL 2,944 m 7% Up 5% Up private medical insurance • EBITDA growth in line with top-line despite the salary increase in January and dilutive effect of new hospit
Slide 5: Expanding its Footprint in Türkiye and Abroad
Expanding its Footprint in Türkiye and Abroad 2024 New Hospitals Bed Capacity Square Meters Consolidation Capacity Starting From +6.300 Bed MP İncek - Ankara 182 8.225 May, 2024 MP İzmir 143 12.500 June, 2024 10% MP Gebze - Kocaeli 100 18.000 July, 2024 MP Ataşehir – İstanbul 80 8.000 July, 2024 MP
Slide 6: Burcu Öztürk, CFO
Slide 7: Revenue is up by 7%
Revenue is up by 7% Revenue (TLm) 6.9% 11.754 10.993 Q1 2024 Q1 2025 Denotes growth of Revenue vs. the same period of the last year 7
Slide 8: Continued Improvement in Average Prices
Continued Improvement in Average Prices Outpatient Revenues (TLm) Inpatient Revenues (TLm) 17.2% 8.5% 14.0% 10.7% 16.5% 3.2% 6.6% Average Revenue Per Visit (ARPV) Average Revenue Per Protocol (ARPP) 14.0% 15.1% 4.248 20.698 17.985 3.725 Q1 2024 Q1 2025 Q1 2024 Q1 2025 Inpatient and Outpatient reve
Slide 9: EBITDA is up by 5%
EBITDA is up by 5% EBITDA (TLm)1 4.8% 25.5% 25.0% 2.944 2.809 Q1 2024 Q1 2025 1 EBITDA and EBITDA margin calculated by deducting general administrative expenses from gross profit and adding depreciation and amortization expenses Denotes growth of EBITDA vs. the same period of the last year Denotes E
Slide 10: Prudent Cost Management
Prudent Cost Management Cost of Service and G&A Expenses as a % of Revenues Cost Saving Measures enables us to reach the favourable EBITDA Margin EBITDA Margin 25.5% 25.0% Material costs as a % of revenue decreased by 217bps due to reduced inventory days 9.3% 10.4% 5.8% 2.7% Doctor costs as a %
Slide 11: Bottom Line Improves
Bottom Line Improves Net Profit (TLm) Net Profit (TLm) Equity Holders of the Parent 22.8% 24.0% 1.276 1.170 943 1.038 Q1 2024 Q1 2025 Q1 2024 Q1 2025 Denotes growth of Net Profit and Net Profit Allocated to Equity Holders of the Parent vs. the same period of the last year 11
Slide 12: Debt Structure: Leverage Ratio Improves
Debt Structure Leverage Ratio Improves Total Debt Total Debt Breakdown Q1 2025 Other; 10.555 216 Bank Loans; 8.793 3.158 Lease Liabilities; Bonds; 6.181 1.000 2024 Q1 2025 Net Debt Net Debt excl. IFRS 16 6.940 5.791 785 759 0.5x 0.6x 0.1x 0.1x 2024 Q1 2025 2024 Q1 2025 *All figures are presented in
Slide 13: Cash Flow
Cash Flow million TL Q1 2024 Q1 2025 Change EBITDA 2,809 2,944 135 Operating Cash Flow decreased due to Changes in working capital 339 (288) (627) temporary growth in trade receivables. Tax paid (316) (380) (64) CAPEX increased due to renovation in Other (564) (704) (139) existing hospitals and
Slide 14: Q&A
Q&A
Slide 15: Closing Remarks
Closing Remarks MUHARREM USTA CHAIRMAN & CEO
Slide 16: Historical Balance Sheet
Historical Balance Sheet Unaudited Audited TLm March 31, 2025 December 31, 2024 Cash and cash equivalents 3,615 3,002 Trade receivables 7,658 6,700 Inventory 902 1,105 Short term other assets 1,640 1,507 Current assets 13,815 12,314 Tangible and intangible fixed assets 18,930 18,665 Right of use ass
Slide 17: Historical P&L Statements
Historical P&L Statements Unaudited Unaudited Change (%) TLm Q1 2025 Q1 2024 Revenues 11,754 10,993 6.9% Cost of service (-) (8,522) (8,127) 4.9% Gross profit 3,232 2,866 12.8% General administration expenses (-) (1,078) (896) 20.3% Other income from operations 518 397 30.4% Other expenses from oper
Slide 18: EBITDA Reconciliation
EBITDA Reconciliation TLm Q1 2025 Q1 2024 Change (%) Revenue 11,754 10,993 6.9% Cost of service (8,522) (8,127) 4.9% Gross profit 3,232 2,866 12.8% General administrative expenses (-) (1,078) (896) 20.3% Depreciation and amortization expenses (Cost of service) 746 779 (4.2%) Depreciation and amortiz